Regulatory Challenges
SESSION 7. Regulatory Challenges
Pharmaceutical companies face a dynamic regulatory landscape that poses numerous challenges. This segment will concentrate on key regulatory hurdles in drug approval processes, including global harmonisation efforts. Strategies for navigating the complexities of FDA and EMA approvals, regulatory flexibility during emergencies, and the impact of regulations on manufacturing will be explored.
Sub-Sessions:
Track 7-1 Regulatory Hurdles in Drug Approval
Track 7-2 Global Regulatory Harmonisation
Track 7-3 Navigating FDA and EMA Approval Processes
Track 17-4 Regulatory Flexibility in Emergencies
Track 7-5 Regulatory Impact on Manufacturing